TH1601002629A - Pyrido[4,3-B]pyrazine-2-carboxamide in the form of nerve-producing substances for Treatment of neurodegenerative disorders - Google Patents

Pyrido[4,3-B]pyrazine-2-carboxamide in the form of nerve-producing substances for Treatment of neurodegenerative disorders

Info

Publication number
TH1601002629A
TH1601002629A TH1601002629A TH1601002629A TH1601002629A TH 1601002629 A TH1601002629 A TH 1601002629A TH 1601002629 A TH1601002629 A TH 1601002629A TH 1601002629 A TH1601002629 A TH 1601002629A TH 1601002629 A TH1601002629 A TH 1601002629A
Authority
TH
Thailand
Prior art keywords
pyrido
pyrazine
carboxamide
nerve
treatment
Prior art date
Application number
TH1601002629A
Other languages
Thai (th)
Other versions
TH165816B (en
TH165816A (en
Inventor
จากาเซียนายโรเเลนด์ จาคอบ โรทเนนายเยนส์ อูเว เพเทอร์สนายเจอร์เกน วิชมันน์ นายราวี
Original Assignee
เอฟ ฮอฟฟ์แมนน์ ลา โรช เอจี
Filing date
Publication date
Application filed by เอฟ ฮอฟฟ์แมนน์ ลา โรช เอจี filed Critical เอฟ ฮอฟฟ์แมนน์ ลา โรช เอจี
Publication of TH165816B publication Critical patent/TH165816B/en
Publication of TH165816A publication Critical patent/TH165816A/en
Publication of TH1601002629A publication Critical patent/TH1601002629A/en

Links

TH1601002629A 2014-11-07 Pyrido[4,3-B]pyrazine-2-carboxamide in the form of nerve-producing substances for Treatment of neurodegenerative disorders TH1601002629A (en)

Publications (3)

Publication Number Publication Date
TH165816B TH165816B (en) 2017-08-10
TH165816A TH165816A (en) 2017-08-10
TH1601002629A true TH1601002629A (en) 2017-08-10

Family

ID=

Similar Documents

Publication Publication Date Title
IL247841A0 (en) Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
HRP20210518T1 (en) 2,4-thiazolidinedione derivatives in the treatment of central nervous system disorders
EP3227330C0 (en) Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases
FI3936130T3 (en) Valbenazine dosage regimen for the treatment of hyperkinetic movement disorders
GB201402070D0 (en) Pharmaceutical compositions for the treatment of inflammatory disorders
HK1244485A1 (en) Combinations for the treatment of neuroblastoma
SG11201608729RA (en) Membrane-adherent self-assembled systems for treatment of ocular disorders
DK3192524T3 (en) HGF PREPARATION SUITABLE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
HUE039750T2 (en) 6-hydroxybuspirone for use in the treatment of movement disorders
SG11201708181RA (en) Methods for the treatment of inflammatory disorders
HK1223916A1 (en) Pyrido[4,3-b]pyrazine-2-carboxamides as neurogenic agents for the treatment of neurodegenerative disorders [43-b]-2-
SG11201702700UA (en) Methods for the treatment of peri-implantitis
MA54630A (en) N,N-BIS-2-MERCAPTOETHYL ISOPHTALAMIDE FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
TH1601002629A (en) Pyrido[4,3-B]pyrazine-2-carboxamide in the form of nerve-producing substances for Treatment of neurodegenerative disorders
PT3370727T (en) Non-bioconvertible c3-substituted pregnenolone derivatives for use in the treatment of substance use disorders
GB201521543D0 (en) Methods for the treatment of inflammatory disorders
ITUB20155450A1 (en) Composition for the treatment of dermatitis.
GB201513993D0 (en) Methods for the treatment of inflammatory disorders
GB201513345D0 (en) Methods for the treatment of Inflammatory disorders
GB201507113D0 (en) Methods for the treatment of inflammatory disorders
GB201506419D0 (en) Methods for the treatment of inflammatory disorders
GB201506229D0 (en) Methods For the Treatment Of Inflammatory Disorders